• PMS51 RETROSPECTIVE ANALYSIS OF INFLIXIMAB DOSING AND INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A COMMERCIALLY-INSURED POPULATION

    May 1, 2009, 00:00

  • PDB59 EFFECT OF CAPITATED MEDICAID HEALTH PLANS ON MEDICATION ADHERENCE AND HEALTH CARE SERVICE UTILIZATIONS IN TYPE-2 DIABETES

    May 1, 2009, 00:00

  • PRS39 ADHERENCE AMONG COPD SUBJECTS ON TIOTROPIUM AND FLUTICASONE/SALMETEROL

    May 1, 2009, 00:00

  • PMC90 MANAGING STUDY PARTICIPANT RECRUITMENT SITES- METHODS FOR OPTIMIZING SUBJECT RECRUITMENT AND RETENTION THROUGH PRIVATE PRACTICE OFFICES

    May 1, 2009, 00:00

  • PCN36 THE ESTIMATED IMPACT OF IN VITRO BIOMARKERS ON THE COSTEFFECTIVENESS OF POPULATION-WIDE COLORECTAL CANCER SCREENING

    May 1, 2009, 00:00

  • PMS17 NATIONAL COST OF ILLNESS STUDY COMPARING VETERAN PATIENTS WITH GOUT TO THOSE WITH DIFFICULT TO MANAGE GOUT

    May 1, 2009, 00:00

  • PHP6 PHYSICIAN KNOWLEDGE OF THE FDA-APPROVED INDICATIONS OF COMMONLY PRESCRIBED DRUGS- RESULTS OF A NATIONAL SURVEY

    May 1, 2009, 00:00

  • HT2 HEALTH TECHNOLOGY ASSESSMENT - A COMPREHENSIVE FRAMEWORK FOR EVIDENCE-BASED RECOMMENDATIONS IN ONTARIO

    May 1, 2009, 00:00

  • PIN34 DOES COMBINING ANTIRETROVIRAL AGENTS IN TO A SINGLE DOSAGE FORM (CO-FORMULATIONS) ENHANCE QUALITY OF LIFE OF HIV/AIDS PATIENTS-A COST UTILITY STUDY

    May 1, 2009, 00:00

  • ND1 COST-EFFECTIVENESS OF DISEASE-MODIFYING THERAPY FOR MULTIPLE SCLEROSIS- A POPULATION-BASED EVALUATION

    May 1, 2009, 00:00

  • PND5 CLINICAL CONSEQUENCES OF GENERIC SWITCHES OF ANTIEPILEPTIC DRUGS-TRANSFER OF CANADIAN CLAIMS DATABASE RESULTS TO GERMANY

    May 1, 2009, 00:00

  • PDB5 SYSTEMATIC REVIEW IN TYPE-2 DIABETES - WHAT IS THE INFLUENCE OF LIFESTYLE CHANGE?

    May 1, 2009, 00:00

  • PDB49 THE EFFECT OF READINESS TO CHANGE ON MEASURES OF DIABETES CONTROL AND ATTITUDES TOWARDS DIABETES

    May 1, 2009, 00:00

  • PHP23 DRUG USE AND EXPENDITURES FOR PART D ENROLLED SENIORS WHO REACHED THE COVERAGE GAP IN 2007

    May 1, 2009, 00:00

  • PHP33 UNMET PRESCRIPTION MEDICATION NEED DUE TO COST, HEALTH PLAN PROBLEM, AND LACK OF INSURANCE OF CHILDREN IN THE UNITED STATES- RESULTS FROM NATIONAL SURVEY OF CHILDRENS HEALTH 2003 DATA

    May 1, 2009, 00:00

  • PHP88 IDENTIFYING KEY DECISION PATHWAYS IN HEALTH TECHNOLOGY ASSESSMENT AROUND THE WORLD

    May 1, 2009, 00:00

  • PHP32 EQUITY AND ACCESS TO GENERIC DRUGS- A COMPARISON OF GENERIC DRUG DISCOUNT PROGRAMS OFFERED BY CHAIN PHARMACIES IN THE UNITED STATES

    May 1, 2009, 00:00

  • QL2 DEVELOPMENT OF AN ITEM BANK FOR A COMPUTER ADAPTIVE MEASURE OF FUNCTIONAL COGNITION FOR STROKE

    May 1, 2009, 00:00

  • PND13 A COST-CONSEQUENCES ANALYSIS OF THE IMPACT OF A-RATED ANTI-EPILEPTIC DRUG SWITCHING- THE MANAGED CARE PLAN PERSPECTIVE

    May 1, 2009, 00:00

  • PCN81 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF COLORECTAL CANCER IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PMH56 MEDICATION SATISFACTION IN SUBJECTS WITH SCHIZOPHRENIA TREATED WITH PALIPERIDONE ER AFTER SUBOPTIMAL RESPONSE TO ORAL RISPERIDONE

    May 1, 2009, 00:00

  • PMC44 DEVELOPMENT OF AN INTERACTIVE MODEL TO EVALUATE THE ECONOMIC IMPACT OF CHD EVENTS AMONG ADULTS WITH DYSLIPIDEMIA FROM AN EMPLOYER PERSPECTIVE

    May 1, 2009, 00:00

  • PHP27 OPTIMIZING THE USE OF MEDICATION IN THE INTRAVENOUS COMPOUND CENTER OF THE CMNO

    May 1, 2009, 00:00

  • PRS19 HOW MUCH WOULD AMERICA SAVE IF ASTHMA DID NOT EXIST?

    May 1, 2009, 00:00

  • PIH47 POTENTIALLY INAPPROPRIATE MEDICATION USE IN ELDERLY USING JAPANESE BEERS CRITERIA

    May 1, 2009, 00:00

  • PMC54 ARE YOUNG CHILDREN ABLE TO MAKE TRADE-OFFS? A QUALITATIVE STUDY OF CHILDREN AGED 6 TO 12 YEARS AND THEIR PERCEPTIONS OF INFLUENZA VACCINATION

    May 1, 2009, 00:00

  • UT1 ON THE ISSUE OF UTILITY MULTIPLICATION- A REVISIT

    May 1, 2009, 00:00

  • PM4 AN EXPLORATION OF THE POTENTIAL CLINICAL BENEFITS AND RISKS OF CYP2D6 TESTING TO GUIDE TAMOXIFEN THERAPY IN BREAST CANCER

    May 1, 2009, 00:00

  • PIN1 STATISTICAL ANALYSIS OF MONONUCLEOSIS IN ADOLESCENTS

    May 1, 2009, 00:00

  • PRS16 AN ECONOMIC EVALUATION OF A PHARMACOLOGICAL INTERVENTION USING VARENICLINE AS THERAPY FOR SMOKING CESSATION

    May 1, 2009, 00:00

  • FD4 THE EFFECTS OF NICE HTAS ON DRUG PRESCRIBING AND EXPENDITURES IN THE UNITED STATES

    May 1, 2009, 00:00

  • MD1 NONADHERENCE WITH ORAL HYPOGLYCEMICS AMONG MEDICARE PART D ENROLLEES WITH DIABETES

    May 1, 2009, 00:00

  • CO2 METHODS FOR INTERPRETING AND DISPLAYING RESULTS- FROM REGRESSION MODELS- BEYOND BETAS AND ODDS RATIOS

    May 1, 2009, 00:00

  • PIH22 ESTIMATING DIRECT COST OF VAGINITIS IN TURKEY

    May 1, 2009, 00:00

  • PIH44 WORK PRODUCTIVITY OF WOMEN EXPERIENCING DOMESTIC VIOLENCE

    May 1, 2009, 00:00

  • PRS18 THE ECONOMIC BURDEN OF CHRONIC OBSTRUCTION PULMONARY DISEASE DUE TO SMOKING

    May 1, 2009, 00:00

  • PMS8 BIOLOGIC THERAPY REDUCES PATIENT-REPORTED SEVERITY OF RHEUMATOID ARTHRITIS IN THE REAL WORLD SETTING

    May 1, 2009, 00:00

  • CM1 ASSOCIATION BETWEEN INSURANCE GAPS AND ANTIHYPERTENSION MEDICATION ADHERENCE IN A NATIONAL REPRESENTATIVE SAMPLE IN THE UNITED STATES

    May 1, 2009, 00:00

  • CV3 THE IMPACT OF PROTON PUMP INHIBITORS ON CARDIOVASCULARRELATED EVENT COSTS IN PATIENTS INITIATING CLOPIDOGREL

    May 1, 2009, 00:00

  • UT3 THE VALUE OF ADDED LIFE YEARS AS A FUNCTION OF AGE, PROGNOSIS AND QUALITY OF LIFE

    May 1, 2009, 00:00

  • PCV32 HEALTH ECONOMICS EVALUATION ON PERCUTANEOUS CORONARY INTERVENTION(PCI) IN CHINA

    May 1, 2009, 00:00

  • PCN49 COLORECTAL CANCER SCREENING FOR AVERAGE RISK INDIVIDUALS- AN ECONOMIC EVALUATION

    May 1, 2009, 00:00

  • PCV37 ECONOMIC IMPACT OF EDARAVONE THERAPY FOR PATIENTS WITH LACUNAR INFARCTION IN JAPAN

    May 1, 2009, 00:00

  • PCV6 BURDEN OF HYPERLIPIDEMIA AND ASSOCIATED TREATMENT PATTERNS IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PND24 BURDEN OF MULTIPLE SCLEROSIS ON HEALTH-RELATED QUALITY OF LIFE- BASELINE FINDINGS FROM AN OBSERVATIONAL STUDY

    May 1, 2009, 00:00

  • PDB51 ASSOCIATION BETWEEN MEDICATION ADHERENCE AND HBA1C LEVELS IN DIABETIC PARTICIPANTS ENROLLED IN A DISEASE MANAGEMENT PROGRAM

    May 1, 2009, 00:00

  • PCN10 LUNG CANCER IN THE CHINESE PASSIVE SMOKING POPULATIONS

    May 1, 2009, 00:00

  • PHP4 CHANGES OF THE CASE-MIX INDEX OF THE HUNGARIAN INTENSIVE CARE UNITS

    May 1, 2009, 00:00

  • PCN17 COST OF MANAGING SIDE EFFECTS OF FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA (MRCC) IN GERMANY, FRANCE, UK AND ITALY- BEVACIZUMAB (BEV) INTERFERON-ALPHA2A COMPARED WITH SUNITINIB

    May 1, 2009, 00:00

  • PCN27 COMPARING AND VALIDATING DIFFERENT TYPES OF PROPENSITY SCORE MATCHING TECHNIQUES

    May 1, 2009, 00:00

  • PMC15 EVALUATING AN ONLINE FREEWARE CALCULATOR FOR A COST EFFECTIVENESS MODEL TO ASSESS THE IMPACT OF MEDICATION COMPLIANCE

    May 1, 2009, 00:00

  • PDB21 ECONOMIC EVALUATION OF RAPID-ACTING INSULIN ANALOGUES FOR THE TREATMENT OF PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS IN CANADA

    May 1, 2009, 00:00

  • PMC22 DIFFERENCE-IN-DIFFERENCE ANALYSIS IN THE EVALUATION OF AN INPATIENT INTERVENTION AMONG PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA

    May 1, 2009, 00:00

  • RA3 A BAYESIAN DECISION-ANALYTIC ECONOMIC MODEL TO OPTIMIZE ALLOCATION OF RISK IN PAY-FOR-PERFORMANCE PAYMENT ARRANGEMENTS

    May 1, 2009, 00:00

  • PRS36 HOSPITAL RESOURCE UTILIZATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE- AN ANALYSIS OF THE 2005 NATIONAL INPATIENT SAMPLE DATA

    May 1, 2009, 00:00

  • PIN19 CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTAGE FOR THE TREATMENT OF SEVERE SEPSIS- A SYSTEMIC REVIEW AND ECONOMIC EVALUATION

    May 1, 2009, 00:00

  • PMH46 PREDICTORS OF DULOXETINE TREATMENT PERSISTENCE FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER

    May 1, 2009, 00:00

  • PIH38 STATISTICAL ANALYSES OF FACTORS AFFECTING LENGTH OG STAY AND TOTAL CHARGES FOR PEDIATRIC PATIENTS AFFLICTED WITH PERINATAL INFECTION

    May 1, 2009, 00:00

  • PIN28 SAVING COSTS FROM INFLUENZA IMMUNIZATION AMONG YOUNG CHILDREN-LIVE ATTENUATED VS. INACTIVATED INFLUENZA VACCINATION

    May 1, 2009, 00:00

  • PIN44 IDENTIFYING PREDICTORS OF HIV PATIENTS SATISFACTION WITH MAIL-ORDER AND COMMUNITY PHARMACY SERVICES

    May 1, 2009, 00:00

  • PHP95 MEDICATION ADMINISTRATION PROCESS CONDUCTED BY NURSES IN INTENSIVE AND ACUTE CARE UNITS OF A HOSPITAL- A TIME AND MOTION STUDY

    May 1, 2009, 00:00

  • PMC50 REGRESSION ESTIMATORS FOR QUALITY OF LIFE AND QUALITYADJUSTED LIFE YEARS (QALYS)

    May 1, 2009, 00:00

  • PIH36 DEVELOPMENT OF A SPECIFIC QUESTIONNAIRE ASSESSING THE IMPACT ON PARENTS OF AN INFANTS BRONCHIOLITIS HOSPITALIZATION

    May 1, 2009, 00:00

  • PUK3 CALCIUM-BASED PHOSPHATE BINDERS LEAD TO INCREASED PROGRESSION OF VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASE

    May 1, 2009, 00:00

  • CM4 NONADHERENCE TO CLINICAL PRACTICE GUIDELINES FOR MULTIPLE DISEASE CONDITIONS IN A CALIFORNIA MEDICAID POPULATION

    May 1, 2009, 00:00

  • PSY17 DECISION-ANALYTIC MODELLING OF TREATMENT OPTIONS FOR PATIENTS WITH SEVERE HAEMOPHILIA A AND INHIBITORS IN GERMANY

    May 1, 2009, 00:00

  • PMC60 DETERMINING THE MINIMALLY IMPORTANT DIFFERENCES OF FOUR PREFERENCE-BASED HEALTH INDICES- A SIMULATION APPROACH

    May 1, 2009, 00:00

  • PMS26 CHARACTERISTICS AND HEALTH CARE UTILIZATION RESULTING FROM INJECTION SITE REACTIONS WITH ANTI-TNF TREATMENTS FOR RHEUMATOID ARTHRITIS- AN ANALYSIS OF CASES AT AN URBAN TEACHING HOSPITAL

    May 1, 2009, 00:00

  • PMC5 PRO AND UTILITY ASSESSMENT- ADDRESSING CONFOUNDS OF CHANGING SELF-REFERENCE

    May 1, 2009, 00:00

  • PIN37 SELF-REPORTED PILL BURDEN AS A PREDICTOR FOR ADHERENCE IN HIV-INFECTED PATIENTS

    May 1, 2009, 00:00

  • CO3 ESTIMATING DRUG COSTS IN ECONOMIC EVALUATIONS IN IRELAND AND THE UK- AN ANALYSIS OF PRACTICE AND RESEARCH RECOMMENDATIONS

    May 1, 2009, 00:00

  • PSS10 ECONOMIC BURDEN OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS IN CANADA

    May 1, 2009, 00:00

  • PCN6 USING PREDICTIVE MODELS TO ANALYZE LUNG CANCER DATA

    May 1, 2009, 00:00

  • PSY40 FEASIBILITY OF DAILY DIARIES WITH QOL ASSESSMENT IN CONGENTIAL HEMOPHILIA PATIENTS WITH ALLOANTIBODY INHIBITORS

    May 1, 2009, 00:00

  • PHP28 TRENDS IN BEERS DRUG USE IN THE DUALLY ELIGIBLE MEDICARE AND MEDICAID POPULATION USING THE 1997 BEERS DRUG LIST FROM 1999 THROUGH 2004

    May 1, 2009, 00:00

  • PMC76 AN ASSESSMENT OF THE EVIDENCE TO SUPPORT THE USE OF LINGUISTIC VALIDATION INTERVIEWS AS AN INTEGRAL PART OF THE TRANSLATION OF PROS FOR USE IN MULTI-NATIONAL TRIALS

    May 1, 2009, 00:00

  • PCV82 FRACTION OF NURSING HOME ADMISSION AND INCREMENTAL COST ATTRIBUTABLE TO NON ADHERENCE TO ANTI HYPERTENSIVE MEDICATIONS

    May 1, 2009, 00:00

  • PMC61 MEASURING POPULATION HEALTH STATUS USING EQ-5D- RESULTS FROM THE HEALTH SURVEY FOR ENGLAND 1996-2006

    May 1, 2009, 00:00

  • PIN38 PATIENT PREFERENCES AND STATED ADHERENCE FOR HEPATITIS C VIRUS TREATMENTS

    May 1, 2009, 00:00

  • PSY16 A CANADIAN BASED PHARMACOECONOMIC ANALYSIS OF SELECTED ANTICONVULSANTS, SNRIS AND TCAS IN TREATING NEUROPATHIC PAIN

    May 1, 2009, 00:00

  • PMC23 WHERE IS THE CURRENT FOCUS OF HEALTH ECONOMICS? AN INVESTIGATION INTO THE PUBLISHED LITERATURE WITHIN THREE KEY HEALTH ECONOMICS JOURNALS

    May 1, 2009, 00:00

  • PRS31 ASSOCIATION BETWEEN COMPLIANCE AND RESPIRATORY-RELATED COSTS FOR PATIENTS WITH COPD TREATED WITH MAINTENANCE THERAPY

    May 1, 2009, 00:00

  • PMS40 UTILITY AND QUALITY OF LIFE OF PATIENTS WITH OSTEOARTHRITIS TREATED WITH THE CYCLOOXYGENASE INHIBITING NITRIC OXIDE DONATOR (CINOD) NAPROXCINOD

    May 1, 2009, 00:00

  • PCV89 DIABETES MANAGEMENT AND KNOWLEDGE IMPROVEMENTS AS A RESULT OF PATIENT EDUCATION- A COMMUNITY BASED, RANDOMIZED CLINICAL TRIAL

    May 1, 2009, 00:00

  • PHP87 THE IMPACT OF THE SUBMISSION SEQUENCE - WHICH APPRAISING BODY TO SUBMIT TO FIRST?

    May 1, 2009, 00:00

  • PCN7 CLINICAL AND ECONOMIC OUTCOMES IN CANCER CHEMOTHERAPY PATIENTS INITIATED ON ERYTHROPOIESIS STIMULATING AGENTS (ESA) AT HEMOGLOBIN (HB) LEVELS 10 G/DL

    May 1, 2009, 00:00

  • VA4 COMPARING COST-EFFECTIVENESS RESULTS- OF A CROSS-SECTIONAL POPULATION MODEL WITH A COHORT MODEL- THE APPLICATION TO PNEUMOCOCCAL CONJUGATE VACCINATION

    May 1, 2009, 00:00

  • PCV106 CREATING A QUALITY INDEX TO RANK HOSPITALS

    May 1, 2009, 00:00

  • DU1 PHYSICAL FUNCTION AND THE CONCOMITANT USE OF ANTICHOLINERGIC ANTIHISTAMINES AND CHOLINESTERASE INHIBITORS AMONG MEDICAID RECIPIENTS WITH DEMENTIA

    May 1, 2009, 00:00

  • PMS32 HIGHER OUT-OF-POCKET PHARMACY EXPENSE IS ASSOCIATED WITH HIGHER SWITCHING RATES AMONG ANTI-TUMOR NECROSIS FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PSY45 CURTAILING LAB-TEST ORDERING IN A MANAGED CARE SETTING THROUGH REDESIGN OF A COMPUTERIZED ORDER-FORM

    May 1, 2009, 00:00

  • PCV34 FINANCIAL ASSESSMENT OF A COMPREHENSIVE CARDIAC CARE PROGRAM FOR PATIENTS WITH OCCULSIVE CORONARY ARTERY DISEASE

    May 1, 2009, 00:00

  • PCN82 HFS 14- A SPECIFIC QUALITY OF LIFE INSTRUMENT FOR PATIENTS WITH HAND-FOOT SYNDROME

    May 1, 2009, 00:00

  • RA1 CAN THE PUBLICS RISK/BENEFIT BE TRUSTED?

    May 1, 2009, 00:00

  • PMH19 ECONOMIC ASSESSMENT OF SECOND-LINE TREATMENT- SWITCHING FROM A GENERIC SSRI TO ESCITALOPRAM, AN SNRI, OR ANOTHER GENERIC SSRI BY PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)

    May 1, 2009, 00:00

  • PMC46 A REVIEW OF THE EVOLUTION OF HEALTH ECONOMIC MODELS OF SMOKING CESSATION

    May 1, 2009, 00:00

  • PGI8 COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO

    May 1, 2009, 00:00

  • PIN5 PHARMACOGENOMICS- APPLICABILITY IN ANTIRETRO VIRAL THERAPY (ART) IN HIV PATIENTS

    May 1, 2009, 00:00

  • PCV36 THE IMPACT OF A STATIN FORMULARY CHANGE ON HEALTH OUTCOMES AND MEDICAL COSTS

    May 1, 2009, 00:00

  • PSY42 USTEKINUMAB REDUCES ITCH, BODILY PAIN, AND FATIGUE IN PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS

    May 1, 2009, 00:00

  • PMS50 A PRELIMINARY ANALYSIS OF BIOLOGICS MEDICATION-TAKING BEHAVIOR AMONG RHEUMATOID ARTHRITIS PATIENTS

    May 1, 2009, 00:00

  • PDB15 UTILIZATION PATTERNS AND HYPOGLYCEMIA IN PATIENTS WITH TYPE-2 DIABETES ON CONCOMITANT EXENATIDE AND LONG-ACTING INSULIN THERAPY

    May 1, 2009, 00:00

  • PND14 COST OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PCV9 COMPARATIVE EFFECTIVENESS OF INDIVIDUAL ANGIOTENSINCONVERTING ENZYME INHIBITORS IN PATIENTS WITH CHRONIC HEART FAILURE

    May 1, 2009, 00:00

  • PMS41 AN ASSESSMENT OF SELF REPORTED OUTCOMES IN A NATIONALLY REPRESENTATIVE SAMPLE OF ELDERLY PERSON DIAGNOSED WITH RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PSY50 REVENUES FROM VENDED BEVERAGES IN WEST VIRGINIA PUBLIC SCHOOLS

    May 1, 2009, 00:00

  • PIN21 VARIATION IN EFFICIENCY FRONTIERS FOR HIV/AIDS PREVENTION AND TREATMENT

    May 1, 2009, 00:00

  • PIN2 FACTORS INFLUENCING PEDIATRIC PATIENTS WITH PNEUMONIA

    May 1, 2009, 00:00

  • PIH15 COST EFFECTIVENESS ANALYSIS OF GOSERELIN EMPIRIC THERAPY FOR DEEP ENDOMETRIOSIS TREATMENT

    May 1, 2009, 00:00

  • PMC72 ASSESSING ANXIETY AND DEPRESSION ON AN INTERNATIONAL LEVEL

    May 1, 2009, 00:00

  • PMC29 DEVELOPMENT OF A REGULATORY POST-MARKETING STUDIES DATABASE

    May 1, 2009, 00:00

  • PIH30 PATTERNS OF UTILIZATION AND DISCONTINUATION OF MEDICATION IN A RETIREE POPULATION

    May 1, 2009, 00:00

  • PDB47 THE ASSOCIATION BETWEEN PATIENT-REPORTED DIABETES SYMPTOMS AND TOLERABILITY ISSUES OF ORAL ANTIDIABETIC AGENTS ON WORK AND LIFE PRODUCTIVITY

    May 1, 2009, 00:00

  • PCV52 ECONOMIC EVALUATION OF DALTEPARIN FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) AFTER TOTAL KNEE ARTHROPLASTY IN MEXICO

    May 1, 2009, 00:00

  • PCN46 PHARMACOECONOMIC EVALUATION OF SUNITINIB MALATE FOR FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO

    May 1, 2009, 00:00

  • PSY52 ESTIMATION OF CLINICAL AND ECONOMIC IMPACT OF CHRONIC PAIN ON THE BENEFICIARIES OF A PRIVATE HEALTH PLAN IN BRAZIL

    May 1, 2009, 00:00

  • PHP5 MARKET SHARE OF INTENSIVE CARE UNITS IN HUNGARY ACCORDING TO THE DRG SYSTEM

    May 1, 2009, 00:00

  • PMC75 MEANINGFUL VERSUS USEABLE RESPONSES TO PREFERENCE SURVEYS- INSIGHTS INTO IMPROVING THE VALIDITY OF HEALTH UTILITY SCORES

    May 1, 2009, 00:00

  • PCN28 RETROSPECTIVE CLAIMS DATABASE ANALYSIS OF THE DIRECT MEDICAL COSTS ASSOCIATED WITH SORAFENIB AND SUNITINIB IN THE TREATMENT OF PATIENTS WITH RENAL CELL CARCINOMA WHO ARE UNDER 65 YEARS OLD

    May 1, 2009, 00:00

  • PDB11 EFFECT OF ACE INHIBITORS AND ARBS ON INCIDENCE OF RENAL DISEASE IN ELDERLY PATIENTS WITH DIABETES

    May 1, 2009, 00:00

  • PCV42 INCREMENTAL COST-EFFECTIVENESS ANALYSIS OF ANGIOTENSIN RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS IN A US MANAGED CARE POPULATION

    May 1, 2009, 00:00

  • PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2009, 00:00

  • PMC86 THE IMPACT OF DISEASE ADAPTATION ON GENERAL POPULATION VALUES

    May 1, 2009, 00:00

  • PMS4 RISK FACTORS FOR INCIDENT GOUT AMONG WOMEN- A PROSPECTIVE STUDY

    May 1, 2009, 00:00

  • PND23 PREVALENCE OF TREATMENT GAPS IN MULTIPLE SCLEROSIS PATIENTS RECEIVING DISEASE-MODIFYING DRUGS- FINDINGS FROM A NATIONAL MANAGED CARE DATABASE

    May 1, 2009, 00:00

  • PMC53 SHOULD AN SF-10 REPLACE THE SF-12?

    May 1, 2009, 00:00

  • PCN77 HEALTH CARE RESOURCE UTILIZATION ASSOCIATED WITH ESCALATING IMATINIB VERSUS SWITCHING TO DASATINIB IN PATIENTS WITH CHRONIC MYELEGENOUS LEUKEMIA

    May 1, 2009, 00:00

  • DISCLOSURE INFORMATION

    May 1, 2009, 00:00

  • PCV72 COST-EFFECTIVENESS ANALYSIS OF ADD-ON ALISKIREN TO LOSARTAN TREATMENT FOR PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN THE CZECH PATIENTS FROM PAYOR PERSPECTIVE

    May 1, 2009, 00:00

  • PCV68 ADMINISTRATIVE CLAIMS IN A LARGE BRAZILIAN NATIONWIDE DATABASE- A DESCRIPTIVE ANALYSIS OF THE DIRECT MEDICAL COSTS OF CORONARY ARTERY BYPASS GRAFTING (CABG) AMONG DIFFERENT REGIONS IN A CONTINENTAL-SIZE COUNTRY

    May 1, 2009, 00:00

  • MO4 RE-EXAMINING THE SPECIFICATION OF REGRESSION MODELS OF MULTINOMIAL RESPONSES- AN APPLICATION TO PREDICTING POSTSTROKE DISCHARGE DISPOSITION

    May 1, 2009, 00:00

  • PND3 PREVALENCE OF ALZHEIMERS DISEASE AND RELATED DEMENTIA AND THE CO-EXISTING CONDITIONS IN MANAGED CARE ORGANIZATIONS

    May 1, 2009, 00:00

  • MD8 OUT OF POCKET PSYCHOTROPIC PRESCRIPTION BURDEN ON ELDERLY MEDICARE BENEFICIARIES BEFORE AND AFTER THE IMPLEMENTATION OF MEDICARE PART D

    May 1, 2009, 00:00

  • PCV110 DO CANADIAN PHYSICIANS CORRECTLY IDENTIFY HIGH RISK CV PATIENTS?

    May 1, 2009, 00:00

  • PUK16 THE BRAZILIAN PORTUGUESE VALIDATION OF THE URINARY INCONTINENCE-SPECIFIC QUALITY OF LIFE INSTRUMENT- I-QOL

    May 1, 2009, 00:00

  • QL4 VALIDATION OF THE TREATMENT RELATED IMPACT MEASURE FOR DIABETES TREATMENT AND DEVICE; TRIMXD -DIABETES AND TRIM-DIABETES DEVICE

    May 1, 2009, 00:00

  • PCN5 GAINS ASSOCIATED WITH CLINICAL EXAMS AND MAMMOGRAPHIC SCREENING FOR WOMEN ABOVE 40 YEARS OF AGE

    May 1, 2009, 00:00

  • PMC25 A SYSTEMATIC REVIEW OF BURDEN OF DISEASE STUDIES IN THE ASIA-PACIFIC REGION

    May 1, 2009, 00:00

  • PCN85 TESTING THE MEASUREMENT EQUIVALENCE OF PAPER AND INTERACTIVE VOICE RESPONSE (IVR) VERSIONS OF THE EORTC QLQ-C30

    May 1, 2009, 00:00

  • DB3 DIRECT AND INDIRECT COSTS ASSOCIATED WITH DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

    May 1, 2009, 00:00

  • MO2 A SYSTEMATIC EVALUATION OF EMPIRICAL BAYES METHODS UNDER TIME CENSORED CONDITIONS

    May 1, 2009, 00:00

  • PIH1 ASSESSMENT OF LENGTH OF STAY FOR WOMEN WITH HIGH RISK COMORBIDITIES DURING LABOR AND DELIVERY

    May 1, 2009, 00:00

  • PCV13 CAN THE RELATIONSHIP BETWEEN AGE AND CHOLESTEROL LEVELS INDICATE EFFECTIVENESS OF LIPID LOWERING THERAPY IN PRIMARY CARE? FRANCE, GERMANY, ITALY AND UK

    May 1, 2009, 00:00

  • PHP75 PHYSICIAN KNOWLEDGE AND CONFIDENCE IN APPROPRIATE MEDICATION PRESCRIBING IN THE ELDERLY- A SURVEY STUDY IN PARMA, ITALY

    May 1, 2009, 00:00

  • PRS32 ADJUSTING THE NICOTINE DOSE- THE KEY TO A SUCCESSFUL, 'TAILORED' METHOD OF QUITTING SMOKING

    May 1, 2009, 00:00

  • PSS6 AN ECONOMIC ANALYSIS TO EVALUATE ANTI-GLAUCOMA PHARMACOTHERAPY

    May 1, 2009, 00:00

  • PCN3 THE FEASIBILITY AND COST OF EARLY DETECTION OF PROSTATE CANCER IN GASTROENTEROLOGY UNITS

    May 1, 2009, 00:00

  • PCV97 TEN-YEARS FOLLOW-UP OF ANTI-HYPERTENSIVE MEDICATIONS WITHIN THE SLOVAK REPUBLIC

    May 1, 2009, 00:00

  • PIH2 CLINICAL AND COST OUTCOMES AMONG PATIENTS ON WARFARIN WITH ELECTRONIC ALERTS TO REMIND PROVIDERS ABOUT HIGH INTERNATIONAL NORMALIZED RATIO

    May 1, 2009, 00:00

  • PDB60 ASSESSMENT OF THE INTERVAL BETWEEN FIRST EXENATIDE CLAIM AND LAST PRIOR ORAL ANTIDIABETIC CLAIM

    May 1, 2009, 00:00

  • PMC35 USE OF CLASSIFICATION TREES AS AN AID IN UNDERSTANDING MISSING DATA- AN EXAMPLE FROM AN INTERNET-BASED SURVEY OF PATIENT CHARACTERISTICS AND RESOURCE UTILIZATION

    May 1, 2009, 00:00

  • PHP74 RED BLOOD CELL TRANSFUSION PRACTICES IN VA INTENSIVE CARE UNITS- HOW DO THEY VARY FOR PATIENTS WITH HEART AND CHRONIC KIDNEY DISEASE?

    May 1, 2009, 00:00

  • PSY5 THE USEFULNESS OF REGISTRY DATA FOR UNDERSTANDING TREATMENT PRACTICES AND CLINICAL OUTCOMES IN HEMOPHILIA- THE EXPERIENCE OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY (2004-2008)

    May 1, 2009, 00:00

  • PMH34 TREATMENT BURDEN AND COSTS OF LISDEXAMFETAMINE DIMESYLATE USERS COMPARED WITH USERS OF OTHER LONGACTING TREATMENTS IN PATIENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

    May 1, 2009, 00:00

  • PMC12 VALIDATION OF HEALTH CARE RESOURCE USE QUESTIONNAIRES IN MEXICO

    May 1, 2009, 00:00

  • PMH31 ASSOCIATION BETWEEN CHOICE OF ANTIPSYCHOTIC TREATMENT AND SUBSEQUENT COSTS OF MEDICAL CARE IN PATIENTS WITH BIPOLAR DISORDER

    May 1, 2009, 00:00

  • PCV14 CLINICAL AND ECONOMIC OUTCOMES IN PATIENTS SWITCHED TO SIMVASTATIN IN A COMMUNITY-BASED PRIMARY CARE SETTING

    May 1, 2009, 00:00

  • PCV65 MANAGEMENT OF PRIMARY ATRIAL FIBRILLATION (AF)- PATIENT CHARACTERISTICS AND HOSPITAL CARE SETTING

    May 1, 2009, 00:00

  • PSY6 CONTRIBUTIONS OF THE HUNTER OUTCOME SURVEY (HOS) TO ADVANCING UNDERSTANDING OF HUNTER SYNDROME

    May 1, 2009, 00:00

  • PDB37 HYBRID APPLICATIONS OF EXACT COVARIATE MATCHING AND PROPENSITY SCORE IN THE EVALUATION OF PATIENT PERSISTENCE

    May 1, 2009, 00:00

  • PIN12 COST-EFFECTIVENESS ANALYSIS OF DAPTOMYCIN VERSUS VANCOMYCIN IN COMPLICATED SKIN AND SOFT STRUCTURE INFECTION (CSSSI) USING A DECISION ANALYTIC MODEL

    May 1, 2009, 00:00

  • HM4 THE IMPACT OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY MANAGEMENT PROGRAM ON MEDICATION AND HEALTH-RELATED PROBLEMS, MEDICATION ADHERENCE, AND TOTAL DRUG COSTS AMONG MEDICARE BENEFICIARIES- A 6-MONTH FOLLOW-UP

    May 1, 2009, 00:00

  • PCN72 COST-UTILITY ANALYSIS OF GEFITINIB VERSUS DOCETAXEL IN A MEXICAN PUBLIC INSTITUTION

    May 1, 2009, 00:00

  • PDB20 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY

    May 1, 2009, 00:00

  • PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES

    May 1, 2009, 00:00

  • PMH61 THE EFFECTS OF ANTIDEPRESSANT STEP-THERAPY PROTOCOLS ON PHARMACEUTICAL AND MEDICAL UTILIZATION AND EXPENDITURES

    May 1, 2009, 00:00

  • RR2 HEALTH CARE UTILIZATION AND COST OF COPD IN A MEDICAID POPULATION- THE ROLE OF CO-MORBID CONDITIONS

    May 1, 2009, 00:00

  • PSY48 IMPACT OF DIFFERENT WEIGHT CONTROL MEASURES TAKEN BY THE STUDENTS ON THEIR WEIGHT

    May 1, 2009, 00:00

  • PCN93 ONCOLOGIC PATIENT SATISFACTION IN ONCOLOGIC SERVICES IN A TERTIARY REFERRAL CENTER AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PCV45 ECONOMIC ANALYSIS OF THE INSERTABLE CARDIAC MONITOR IN DIAGNOSIS OF SYNCOPE COMPARED TO CONVENTIONAL DIAGNOSTICS- A CANADIAN PERSPECTIVE

    May 1, 2009, 00:00

  • PMH57 JOB SATISFACTION AMONG HOSPITAL PHARMACISTS IN TAIWAN

    May 1, 2009, 00:00

  • PND41 DETECTION OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY REPORTS ASSOCIATED WITH NATALIZUMAB PRE- AND POST-RISK MINIMIZATION ACTION PLAN FROM ADVERSE EVENT REPORTING SYSTEM DATABASE

    May 1, 2009, 00:00

  • PMC16 EVALUATING AN ONLINE FREEWARE CALCULATOR AND PLOTTER FOR POWER ANALYSIS AND SAMPLE SIZE ESTIMATION FOR COST EFFECTIVENESS STUDIES

    May 1, 2009, 00:00

  • PMS22 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS. RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

    May 1, 2009, 00:00

  • PIN55 VALIDATING LIKERT-TYPE MEASURES USING NONPARAMETRIC AND PARAMETRIC ITEM RESPONSE THEORY

    May 1, 2009, 00:00

  • PCN22 PHARMACOECONOMIC APPLICATIONS IN FORMULARY MANAGEMENT- BUDGET IMPACT ANALYSIS OF CLORFARABINE AT A MAJOR CANCER CENTER

    May 1, 2009, 00:00

  • PND25 THE IMPACT OF LENNOX-GASTAUT SYNDROME (LGS) ON HEALTH RELATED QUALITY OF LIFE - A CONCEPTUAL MODEL

    May 1, 2009, 00:00

  • PHP41 POCKET EXPENSES IN HEALTH IN COLOMBIA PER INCOME, 1997-2003

    May 1, 2009, 00:00

  • PIN17 COST EFFECTIVE FOR HPV VACCINE

    May 1, 2009, 00:00

  • PRS2 DOES ADD-ON EVENING DOSE OF FORMOTEROL IMPROVE LUNG FUNCTION FOR COPD PATIENTS RECEIVING FIXED-DOSE OF TIOTROPIUM AND FORMOTEROL?

    May 1, 2009, 00:00

  • PCV28 THE CLINICAL IMPACT OF DIFFERENCES BETWEEN TWO MEASURES OF THE INTERNATIONAL NORMALIZED RATIO (INR)

    May 1, 2009, 00:00

  • PDB28 EXCESS COSTS OF DIABETES MELLITUS AMONG MEDICARE RECIPIENTS IN A SKILLED NURSING FACILITY SETTING

    May 1, 2009, 00:00

  • Abstracts Index

    May 1, 2009, 00:00

  • PRS17 A COST-CONSEQUENCE ANALYSIS COMPARING AN ESTABLISHED AND A NOVEL EPINEPHRINE AUTO-INJECTOR FOR ANAPHYLAXIS

    May 1, 2009, 00:00

  • PRS1 SMOKING CESSATION AND ITS PREDICTORS- RESULTS FROM COMMUNITY BASED PHARMACY TOBACCO CESSATION PROGRAM IN NEW MEXICO

    May 1, 2009, 00:00

  • PMH58 OUTCOMES ASSESSMENT OF AN ANTIPSYCHOTIC DRUG ALGORITHM- EFFECTS OF THE MISSISSIPPI STATE HOSPITAL ALGORITHM PROJECT

    May 1, 2009, 00:00

  • PIH40 ASSESSING WORK PRODUCTIVITY IMPAIRMENT IN PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHRORIC DISORDER

    May 1, 2009, 00:00

  • PCN37 AN ECONOMIC EVALUATION OF CIRCULATING TUMOR CELLS DETECTION IN METASTATIC BREAST CANCER

    May 1, 2009, 00:00

  • PMS24 LOWER HIP FRACTURE RATES IN THE FIRST YEAR OF THERAPY TRANSLATE INTO FAVORABLE COST-EFFECTIVENESS FOR RISEDRONATE VS. GENERIC ALENDRONATE AMONG HIGH RISK PATIENTS

    May 1, 2009, 00:00

  • PMH88 A SYSTEMATIC EVALUATION OF PUBLISHED LITERATURE TO ASSESS BURDEN OF TREATMENT-RESISTANT DEPRESSION

    May 1, 2009, 00:00

  • PCASE1 CASE STUDY OF CREATING A FORMULARY MANAGEMENT PROCESS AT A COMPREHENSIVE CANCER CENTER IN BANGALORE, INDIA

    May 1, 2009, 00:00

  • PSY14 TOLERABILITY OF INTRAVENOUSLY ADMINISTERED IMMUNE GLOBULIN IN THE HOME SETTING

    May 1, 2009, 00:00

  • ND3 PRESCRIBING PATTERNS AMONG DEMENTIA PATIENTS AT THE VETERANS AFFAIRS MARYLAND HEALTH CARE SYSTEM (VAMHCS)

    May 1, 2009, 00:00

  • PMS23 AN ECONOMIC ANALYSIS COMPARING THREE COMBINATIONS OF TUMOR NECROSIS FACTOR-ALPHA AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PRS28 TRENDS IN PREVALENCE OF OBESITY AND MEDICAL COSTS IN ASTHMA PATIENTS IN THE UNITED STATES

    May 1, 2009, 00:00

  • PGI5 PUBLISHED COST-EFFECTIVENESS RESULTS FOR CHRONIC HEPATITIS B AND C-A COMPARATIVE ANALYSIS

    May 1, 2009, 00:00

  • PIN11 MODELING THE INPATIENT AND OUTPATIENT COSTS OF METHICILLIN-RESISTANT STAPHYLOCCOCUS AUREUS (MRSA) COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI)- A COMPARISON OF LINEZOLID, VANCOMYCIN, DAPTOMYCIN, AND TIGECYCLINE

    May 1, 2009, 00:00

  • PHP11 THE IMPACT OF NON-REFERRAL OUTPATIENT CO-PAYMENT ON MEDICAL CARE UTILISATION AND EXPENDITURE IN TAIWAN

    May 1, 2009, 00:00

  • PSY44 USE OF POLYPHARMACY IN PATIENTS WITH FIBROMYALGIA

    May 1, 2009, 00:00

  • PMH64 MEASUREMENTS OF ADHERENCE TO ANTI-DEPRESSANT MEDICATIONS

    May 1, 2009, 00:00

  • PCN19 BUDGET IMPACT ANALYSIS OF SARGRAMOSTIM USE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA

    May 1, 2009, 00:00

  • PDB14 FORECASTING THE NUMBER OF DIABETIC PATIENTS IN THE UNITED STATES THROUGH 2025

    May 1, 2009, 00:00

  • PDB53 SHORT-TERM OUTCOMES FOR AN EMPLOYER SPONSERED PHARMACIST- PROVIDED MULTI CENTER DIABETES MANAGEMENT PROGRAM

    May 1, 2009, 00:00

  • PSS12 COST-UTILITY ANALYSIS OF POSTERIOR LAMELLAR KERATOPLASTY IN CANADA

    May 1, 2009, 00:00

  • PMH75 AUTISM-RELATED HOSPITALIZATIONS- ESTIMATES FROM 2006 HEALTH CARE COST AND UTILIZATION PROJECT KIDS INPATIENT DATABASE

    May 1, 2009, 00:00

  • PND28 THE USE OF ELECTRONIC PATIENT-REPORTED OUTCOMES WITHIN CENTRAL NERVOUS SYSTEM PROTOCOLS

    May 1, 2009, 00:00

  • PMH1 ALPRAZOLAM-RELATED DEATHS IN WEST VIRGINIA

    May 1, 2009, 00:00

  • PCV35 PHARMACOECONOMIC MODEL OF ENOXAPARIN VERSUS HEPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS

    May 1, 2009, 00:00

  • MD3 EFFECT OF LIPID LOWERING DRUG USE ON HOSPITALIZATIONS, EMERGENCY ROOM VISITS, AND MORTALITY IN MEDICARE DIABETIC POPULATION

    May 1, 2009, 00:00

  • PRS40 MEDICATION USE AND ASTHMA CONTROL-ANALYZING ECONOMIC TRADEOFFS USING INSURANCE CLAIMS DATA

    May 1, 2009, 00:00

  • PMC28 LINKAGE OF A MULTI-HOSPITAL DATABASE TO HEALTH PLAN CLAIMS DATA FOR CONTINUUM OF CARE OUTCOMES RESEARCH

    May 1, 2009, 00:00

  • CM2 UTILIZATION AND PERSISTENCE OF ALISKIREN IN A REAL-WORLD ENVIRONMENT

    May 1, 2009, 00:00

  • PMC52 CULTURAL ADAPTATION AND VALIDATION OF A HEATH RELATED QUALITY OF LIFE QUESTIONNAIRE- FUNCTIONAL OUTCOMES OF SLEEP QUESTIONNAIRE

    May 1, 2009, 00:00

  • PCN59 INCIDENCE RATE AND BURDEN OF ILLNESS OF CERVICAL CANCER IN THE UNITED STATES

    May 1, 2009, 00:00

  • PSY15 THE IMPACT OF ADHERENCE ON THE COSTS AND BENEFITS OF INTENSIVE LIFESTYLE MANAGEMENT (ILM) IN OVERWEIGHT AND OBESE PATIENTS AT HIGH RISK FOR TYPE-2 DIABETES MELLITUS (T2DM)

    May 1, 2009, 00:00

  • PCV40 COST-EFFECTIVENESS ANALYSIS OF THE INSERTABLE CARDIAC MONITOR FOR DETECTING RECURRENT ATRIAL FIBRILLATION (AF) FOLLOWING RADIOFREQUENCY CATHETER ABLATION (RCA)- A CANADIAN PERSPECTIVE

    May 1, 2009, 00:00

  • PMH47 REASONS FOR DISCONTINUATION AND CONTINUATION OF ANTIPSYCHOTIC THERAPY FROM PATIENT AND CLINICIAN PERSPECTIVES

    May 1, 2009, 00:00

  • PCV69 A CONCEPTUAL ANALYSIS OF THE COSTS OF CARE FOR A 'MAJOR BLEED' IN STUDIES OF ANTIPLATELET AND ANTITHROMBOTIC THERAPIES

    May 1, 2009, 00:00

  • PIN47 IMPROVING PHYSICIAN ADHERENCE TO GUIDELINES FOR DRUG THERAPY- A RANDOMIZED CONTROLLED TRIAL OF EDUCATIONAL INTERVENTIONS IN A MANAGED CARE SETTING IN ISRAEL

    May 1, 2009, 00:00

  • PSY7 DISEASE FLARES AMONG PATIENTS WITH CROHNS DISEASE

    May 1, 2009, 00:00

  • PHP79 ASSESSING THE QUALITY OF CARE IN ITALYS PRIMARY CARE PRACTICES USING ADMINISTRATIVE DATA. IS IT FEASIBLE?

    May 1, 2009, 00:00

  • PMS21 ECONOMIC EVALUATION OF THE USE OF HYLAN G-F 20 IN THE HANDLING OF SEVERE KNEE OSTEOARTHROSIS

    May 1, 2009, 00:00

  • PCN16 COST OF MANAGING SIDE EFFECTS OF FIRST-LINE BEVACIZUMAB (BEV) LOWER-DOSE INTERFERON-ALPHA2A IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN GERMANY, FRANCE, AND UNITED KINGDOM

    May 1, 2009, 00:00

  • PDB54 DULOXETINE THERAPY AND CHANGES IN OPIOID USE AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS

    May 1, 2009, 00:00

  • PMH16 COST-BENEFIT ANALYSIS OF FOUR ANTIPSYCHOTIC DRUGS FOR THE TREATMENT OF SCHIZOPHRENIA IN COLOMBIA

    May 1, 2009, 00:00

  • PCV62 IDENTIFYING DRIVERS OF POST-HOSPITAL DISCHARGE FOR PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) USING QUANTILE REGRESSIONS

    May 1, 2009, 00:00

  • PHP71 HOW DO MANAGED PHYSICIAN PANELS COMPARE AGAINST NON-PANEL PHYSICIANS FOR THE PURPOSE OF RESEARCH?

    May 1, 2009, 00:00

  • PMS25 COST-EFFECTIVENESS IN OSTEOARTHRITIS PAIN RELIEF TREATMENT WITH NSAIDS - A DETERMINATION AND ESTIMATION OF KEY DRIVERS

    May 1, 2009, 00:00

  • PMH73 DISCREPANCIES BETWEEN KNOWLEDGE, ATTITUDES AND BELIEFS AND THE ACTUAL PRACTICE (KABP) OF PHYSICIANS WHO CARE FOR PATIENTS WITH DEPRESSION AND/OR BIPOLAR DISORDER

    May 1, 2009, 00:00

  • PCV50 COST CONSEQUENCES ANALYSIS OF ANTITHROMBOTIC THERAPIES FOR VENOUS THROMBOEMBOLIC DISEASE (VTE) IN MEDICAL PATIENTS IN MEXICO

    May 1, 2009, 00:00

  • PIN30 ACUTE CARE COSTS OF GRAM-NEGATIVE PNEUMONIA IN THE UNITED STATES- A HEALTH CARE COST AND UTILIZATION PROJECT (HCUP) DATA ANALYSIS

    May 1, 2009, 00:00

  • CASE2 TOWARDS AN INTEGRATED APPROACH TO THE ASSESSMENT OF SURROGATE OUTCOME DATA

    May 1, 2009, 00:00

  • PND17 DIRECT MEDICAL COSTS AND THE LIKELIHOOD OF HEALTH SERVICE UTILIZATION BEFORE AND AFTER INITIATION OF INTERFERON b1A-IM TREATMENT AMONG PERSONS WITH MULTIPLE SCLEROSIS (MS)

    May 1, 2009, 00:00

  • PSS11 ECONOMIC BURDEN OF SEVERE CHRONIC HAND ECZEMA/ DERMATITIS IN CANADIAN ADULTS

    May 1, 2009, 00:00

  • PMH85 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN CHILDREN AND ADOLESCENTS

    May 1, 2009, 00:00

  • PCV17 ASSOCIATION BETWEEN PHARMACY TREATMENT AND OUTCOMES IN PATIENTS WITH CHRONIC HEART FAILURE

    May 1, 2009, 00:00

  • PSY27 THE LONG-TERM COST OF ORTHOPAEDIC SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN HAEMOPHILIA INHIBITOR PATIENTS

    May 1, 2009, 00:00

  • PMH43 UNINTENDED CONSEQUENCES OF CURRENT ANTIDEPRESSANT USE IN A GERIATRIC POPULATION- THE BURDEN OF SIDE-EFFECTS ON ADHERENCE AND COSTS

    May 1, 2009, 00:00

  • PCV57 HEALTH ECONOMIC EVALUATION OF CONTRAST MEDIA IN CORONAROGRAPHY- ISO-OSMOLAR IODIXANOL VS. LOW-OSMOLAR MEDIA

    May 1, 2009, 00:00

  • PMH29 DIRECT COSTS IN OLDER PATIENTS WITH DEPRESSION TREATED AND UNTREATED WITH ANTIDEPRESSANT THERAPY

    May 1, 2009, 00:00

  • PSY33 PROCESS MEASUREMENT AND CALCULATION IN IV-PCA AT UNIVERSITY HOSPITAL OULU FINLAND

    May 1, 2009, 00:00

  • PHP35 THE EFFECT OF THE WITHDRAWAL OF HOSPITAL DAILY FEE ON THE NUMBER OF ADMISSIONS TO ACUTE CARE HOSPITAL WARDS IN HUNGARY

    May 1, 2009, 00:00

  • PCV66 INPATIENT RESOURCE USE AMONG PATIENTS TREATED FOR PRIMARY ATRIAL FIBRILLATION (AF)- ROLE OF CLINICAL FACTORS AND CHOICE OF INITIAL CONVERSION THERAPY

    May 1, 2009, 00:00

  • CN2 WHEN IS CANCER CARE COST-EFFECTIVE? A SYSTEMATIC OVERVIEW OF COST-UTILITY ANALYSES IN ONCOLOGY

    May 1, 2009, 00:00

  • PMS30 THE ECONOMIC CONSEQUENCES OF RHEUMATOID ARTHRITIS- ANALYSIS OF THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS) 2005 AND 2006 DATA

    May 1, 2009, 00:00

  • PND8 THE IMPACT OF GENERIC SUBSTITUTION OF TOPIRAMATE ON HEALTH CARE COSTS- CONVERSION OF THE CANADIAN EXPERIENCE INTO THE SETTINGS OF G4 EUROPEAN COUNTRIES

    May 1, 2009, 00:00

  • PMC64 DEVELOPMENT OF A CHECKLIST TO ASSESS THE QUALITY OF TRANSLATIONS OF PATIENT-REPORTED OUTCOMES (PRO) INSTRUMENTS

    May 1, 2009, 00:00

  • PMC87 COMPARING CHART REVIEW AND MODIFIED DELPHI PANEL RESOURCE DATA COLLECTION METHODS- THE COST OF TREATMENT FOR MULTIPLE MYELOMA IN SWEDEN

    May 1, 2009, 00:00

  • PIH53 IS MEDICARE PART D PLAN BENEFIT DESIGN ASSOCIATED WITH COST-RELATED NONADHERENCE TO PRESCRIPTION DRUGS? AN ANALYSIS USING THE MEDICARE CAHPS DATA

    May 1, 2009, 00:00

  • PHP90 THE IMPACT OF AN ELECTRONIC PRESCRIBING SOLUTION ON THE SELECTION AND PRESCRIBING OF COST-EFFECTIVE THERAPEUTIC OPTIONS

    May 1, 2009, 00:00

  • PDB64 A REVIEW OF RETROSPECTIVE, CONTINUOUS GLUCOSE MONITORING- AN EXAMPLE OF A MEDICAL DEVICE WHERE THE TYPICAL PRIMARY OUTCOME MEASURE MAY BE INAPPROPRIATE?

    May 1, 2009, 00:00

  • PGI9 ECONOMIC ANALYSIS OF THE POTENTIAL USAGES OF ALVIMOPAN AND METHYLNALTREXONE AT A TERTIARY CANCER CENTER

    May 1, 2009, 00:00

  • PIH41 PATIENT SATISFACTION AND PERCIEVED CARE IN OBSTETRICIANS AND GYNECOLOGISTS COMPARED TO OTHER SPECIALTIES- ANALYSIS OF US SELF-REPORTED SURVEY DATA

    May 1, 2009, 00:00

  • PHP52 BUDGETARY POLICIES AND AVAILABLE ACTIONS- A GENERALISATION OF DECISION RULES FOR ALLOCATION AND RESEARCH DECISIONS

    May 1, 2009, 00:00

  • PMH78 HOSPITALIZATION RATES AMONG INDIVIDUALS WITH BIPOLAR DISORDER INITIATING THERAPY WITH ARIPIPRAZOLE OR QUETIAPINE

    May 1, 2009, 00:00

  • DB1 PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES

    May 1, 2009, 00:00

  • QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA

    May 1, 2009, 00:00

  • PMH11 RISK ASSESSMENT OF POISONING WITH DRUGS OF THERAPEUTIC IMPORTANCE BY TOXICOVIGILANCE

    May 1, 2009, 00:00

  • PMH18 HEALTH CARE RESOURCE UTILIZATION ANALYSIS OF PRE/POST LONG-ACTING RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS IN THREE REGIONAL PUBLIC HOSPITALS IN HONG KONG

    May 1, 2009, 00:00

  • PIH24 AN INVESTIGATION OF THE EFFECTS OF GENDER, RACE, AGE, AND OTHER DESCRIPTIVE VARIABLES ON THE LENGTH OF HOSPITALIZATION AND TOTAL HOSPITALIZATION CHARGES ACCRUED BY PEDIATRIC INPATIENTS AFFLICTED WITH PHARYNGITIS

    May 1, 2009, 00:00

  • PDB65 ASSOCIATIONS BETWEEN PATIENT-REPORTED DIABETES KNOWLEDGE AND HEALTH OUTCOMES, SELF-CARE, AND PREFERENCES FOR POTENTIALLY-BENEFICIAL NEW TREATMENT OPTIONS

    May 1, 2009, 00:00

  • PCV5 DEVELOPMENT OF TESTS FOR EARLY DIAGNOSIS OF PREECLAMPSIA

    May 1, 2009, 00:00

  • PND16 ECONOMIC IMPACT OF DISEASE-MODIFYING THERAPIES IN MULTIPLE SCLEROSIS PATIENTS IN A MANAGED CARE SETTING

    May 1, 2009, 00:00

  • RR3 USE OF HEALTH CARE SERVICES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATED WITH BUDESONIDE/FORMOTEROL VIA DRY POWDER INHALER (BUD/FM DPI) VERSUS TIOTROPIUM DPI

    May 1, 2009, 00:00

  • PHP14 HAVE YOUR CAKE OR EAT IT- DO DECISIONS BASED ON COSTEFFECTIVENESS UNDERMINE INCENTIVES FOR RESEARCH AND DEVELOPMENT?

    May 1, 2009, 00:00

  • PDB34 THE EFFECT OF MEDICATION CHOICE BETWEEN DULOXETINE AND PREGABALIN ON MEDICATION COMPLIANCE AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN

    May 1, 2009, 00:00

  • PRS44 QUALITY OF LIFE EVALUATION OF PATIENTS WITH NONTRANSMISSIBLE CHRONIC DISEASES ENROLLED IN A PHARMACY BENEFIT MANAGEMENT

    May 1, 2009, 00:00

  • PDB31 LONG-TERM OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES RECEIVING GLIMEPIRIDE COMBINED WITH LIRAGLUTIDE OR ROSIGLITAZONE

    May 1, 2009, 00:00

  • PMS55 RHEUMATOLOGIST INVOLVEMENT IN CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2009, 00:00

  • PIH11 ECONOMIC EVALUATION ALONGSIDE THE CAFFEINE FOR APNEA OF PREMATURITY (CAP) TRIAL- SHORT TERM OUTCOMES

    May 1, 2009, 00:00

  • PIH31 ASSESSING THE VALUE OF LESS FREQUENT MEDICATION DOSING ON ADHERENCE AND OUTCOMES

    May 1, 2009, 00:00

  • PRS37 WHICH SMOKERS GET ADVICE TO QUIT? VARIABLES ASSOCIATED WITH PHYSICIAN ADVICE FOR SMOKING CESSATION

    May 1, 2009, 00:00

  • PMC63 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE NEUROPATHY TOTAL SYMPTOM SCORE-6 SELF-ASSESSED VERSION (NTSS-6 SA)

    May 1, 2009, 00:00

  • PND7 RELATION OF HEADACHE FREQUENCY TO HEALTH CARE UTILIZATION, WORK PRODUCTIVITY, AND TOTAL COSTS- RESULTS FROM THE AMERICAN MIGRAINE PREVALENCE AND PREVENTION (AMPP) STUDY

    May 1, 2009, 00:00

  • PCN104 HEALTH WORKERS WORK ENVIRONMENT SATISFACTION IN ONCOLOGIC SERVICES AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PSY9 USING UTILIZATION RECORDS TO ESTIMATE THE BURDEN OF OBESITY IN ADULTS LIVING IN ONTARIO

    May 1, 2009, 00:00

  • PDB16 REPLICATION AND VALIDATION OF THE QUANTIFICATION OF THE RELATIONSHIP BETWEEN PHARMACOLOGIC INTERVENTION, REDUCTIONS IN HBA1C AND REDUCTIONS IN COMPLICATIONS- ITS APPLICATION IN QUANTIFYING THE BENEFITS OF ADDING COLESEVELAM HYDROCHLOR ...

    May 1, 2009, 00:00

  • PSS15 CHANGES IN HEALTH RELATED UTILITY AMONG ADULTS WITH ATOPIC DERMATITIS TREATED WITH TACROLIMUS OINTMENT COMPARED TO A STANDARD CORTICOSTEROID REGIMEN

    May 1, 2009, 00:00

  • PSY3 BURDEN OF OBESITY AND ASSOCIATED TREATMENT PATTERNS IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PSY30 ECONOMIC BURDEN OF FIBROMYALGIA COMPARED TO OTHER CHRONIC CONDITIONS

    May 1, 2009, 00:00

  • PMC85 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE PAR-ENT-QOL QUESTIONNAIRE

    May 1, 2009, 00:00

  • PMS42 THE EFFECT OF LIFESTYLE CHOICES ON THE RISK OF IMPAIRMENT IN RHEUMATOID ARTHRITIS PATIENTS- AN ANALYSIS OF AEROBIC EXERCISE AND CIGARETTE SMOKING

    May 1, 2009, 00:00

  • PDB23 ECONOMIC EVALUATION OF METFORMIN, METFORMIN SIBUTRAMIN OR ACARBOSE IN THE MANAGEMENT OF OVERWEIGHT AND OBESE DIABETES PATIENTS

    May 1, 2009, 00:00

  • PGI6 COST EFFECTIVENESS ANALYSIS OF ANTI-TNF-ALPHA; DRUGS FOR REFRACTORY ULCERATIVE COLITIS

    May 1, 2009, 00:00

  • PUK6 ASSESSMENT OF CARDIOVASCULAR (CV) COMORBIDITY IN PATIENTS WITH OVERACTIVE BLADDER (OAB) DISORDER IN A REAL-WORLD SETTING

    May 1, 2009, 00:00

  • PGI14 RESPONSIVENESS TO CHANGE AND CONSTRUCT VALIDITY OF THE WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE FOR GASTROESOPHAGEAL REFLUX DISEASE (WPAI - GERD) IN SWEDISH PATIENTS

    May 1, 2009, 00:00

  • PCV88 EVALUATION OF COMPARATIVE EFFECTIVENESS- A MODEL FOR GENERATING HYPOTHESES AND DETERMINING SAMPLE SIZE

    May 1, 2009, 00:00

  • PGI15 ADULT CANADIANS SUFFERING FROM ACID RELATED DISEASES- PATIENT REPORTED ATTITUDES, PERCEPTIONS, AND IMPACT ON THEIR LIFE

    May 1, 2009, 00:00

  • PHP76 25 YEARS OF ECONOMIC EVALUATION IN MEXICO- A SYSTEMATIC REVIEW OF ARTICLES PUBLISHED IN THE ECONOMIC AND MEDICAL LITERATURE- 1984-2009

    May 1, 2009, 00:00

  • PCV94 ASSESSMENT OF THE STATUS OF HYPERTENSION MANAGEMENT IN NEWLY DIAGNOSED AND ESTABLISHED HYPERTENSION PATIENTS IN PRIMARY CARE PRACTICE

    May 1, 2009, 00:00

  • PCV49 ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR THE NONINVASIVE MANAGEMENT OF PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS)- THE PHARMACOECONOMIC EVALUATION IN RUSSIA

    May 1, 2009, 00:00

  • PMH66 ANTIDEPRESSANTS AND ANTIPSYCHOTICS USE IN CHILDREN-HAS THE UTILIZATION CHANGED AFTER SAFETY WARNINGS?

    May 1, 2009, 00:00

  • PMC13 A QALY ALTERNATIVE FOR COST-EFFECTIVENESS ANALYSIS IN HEALTH CARE

    May 1, 2009, 00:00

  • PHP91 MEDICARE PART DS EFFECT ON PRESCRIBING VOLUME- AVERAGE MONTHLY UTILIZATION OF SELECTED HIGH USE DRUGS IN THE PROTECTED CLASSES BY DIFFERENT SPECIALTIES

    May 1, 2009, 00:00

  • PIN14 THE COST-EFFECTIVENESS OF TRUVADA, KIVEXA AND COMBIVIR IN THE TREATMENT OF ANTIRETROVIRAL NAVE HIV-1 INFECTED PATIENTS IN MEXICO

    May 1, 2009, 00:00

  • PMC32 RELEVANCE OF CONFERENCE ABSTRACTS AND HAND-SEARCHING IN SYSTEMATIC REVIEWS

    May 1, 2009, 00:00

  • PIN29 INFLUENZA- THE DEMOGRAPHICS AND TIME SPENT IN HOSPITALS OF THOSE INFECTED

    May 1, 2009, 00:00

  • PMS36 IMPACT OF A SUPPORT PROGRAM ON THE TREATMENT COMPLIANCE IN OSTEOPOROSIS PATIENTS

    May 1, 2009, 00:00

  • PRS24 INCREMENTAL ASTHMA-RELATED EXPENDITURES ASSOCIATED WITH HIGH UTILIZATION OF SHORT ACTING b-AGONISTS AMONG A COMMERCIALLY INSURED ASTHMATIC POPULATION IN THE U.S.

    May 1, 2009, 00:00

  • PND2 CHRONIC MIGRAINE CRITERIA AND THEIR EFFECTS ON GLOBAL PREVALENCE ESTIMATES- A SYSTEMATIC REVIEW

    May 1, 2009, 00:00

  • CV1 ASSOCIATION OF CARDIOMETABOLIC RISK FACTORS AND PREVALENT CARDIOVASCULAR EVENTS

    May 1, 2009, 00:00

  • PMH63 EFFECTS OF FISCAL INCENTIVES AND SOCIOECONOMIC FACTORS ON ANTIDEPRESSANT ADHERENCE

    May 1, 2009, 00:00

  • PND18 A HEALTH ECONOMIC EVALUATION OF TRANSANAL COLONIC IRRIGATION IN SPINAL CORD INJURY PATIENTS

    May 1, 2009, 00:00

  • PCN74 COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO

    May 1, 2009, 00:00

  • PCV7 BURDEN OF HYPERTENSION AND ASSOCIATED TREATMENT PATTERNS IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PSS17 THE RELATIONSHIP OF DRIVING, VISION, AND QUALITY OF LIFE OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NV-ARMD)

    May 1, 2009, 00:00

  • PHP56 COMPRISON OF NOTIFIABLE DISEASES SURVELLIANCE WEBSITES OF FOUR COUNTRIES

    May 1, 2009, 00:00

  • PHC1 COMPARATIVE EFFECTIVENESS OF LOW INTENSITY PULSED ULTRASOUND VERSUS SHAM TREATMENT OF TIBIA FRACTURE IN PATIENTS WITH NONUNION- A DOUBLE-BLIND, MULTI-CENTER RANDOMIZED CONTROLLED TRIAL

    May 1, 2009, 00:00

  • PHP48 LEGISLATIVE ASPECTS OF HEALTH TECHNOLOGY ASSESSMENT IN SLOVAKIA

    May 1, 2009, 00:00

  • PRS29 CAN OLDER, CHRONICALLY ILL ADULTS USE ELECTRONIC DIARIES? COMPLIANCE RATES IN A PROSPECTIVE STUDY OF PATIENTS WITH COPD

    May 1, 2009, 00:00

  • PCV74 PREDICTED REDUCTION IN HOSPITAL DAYS AND ASSOCIATED COSTS AMONG MANAGED CARE PRIMARY AND SECONDARY RISK MIXED DYSLIPIDEMIA PATIENTS TREATED WITH FIXED DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN COMBINATION THERAPY

    May 1, 2009, 00:00

  • PCV41 ADHERENCE TO GUIDELINES FOR SENSITIVITY ANALYSIS- COSTEFFECTIVENESS ANALYSES OF DUAL ORAL ANTIPLATELET THERAPY

    May 1, 2009, 00:00

  • PMH82 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN ADULTS

    May 1, 2009, 00:00

  • PCV24 DAILY ALCOHOL CONSUMPTION AND RACE/ETHNICITY- THEIR RELATIONSHIP TO STROKE OR CORONARY ARTERY DISEASE IN THE US ADULT POPULATION

    May 1, 2009, 00:00

  • PIH17 COST/EFFECTIVENESS STUDY OF CLOMIPHENE CITRATE VERSUS ANASTROZOLE IN THE INDUCTION OF OVULATION IN BARREN ADULT PATIENTS AT A MEXICAN PUBLIC HOSPITAL

    May 1, 2009, 00:00

  • PCV8 COMPARING CARDIOVASCULAR EVENT RATES OF STATIN PLUS FIBRATE COMBINATION THERAPY WITH STATIN MONOTHERAPY IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS

    May 1, 2009, 00:00

  • PCN54 COST-MINIMIZATION ANALYSIS OF FLUDARABINE ASSOCIATED TO ALEMTUZUMAB (FLUCAM) VERSUS THE ASSOCIATION OF FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) IN THE SECOND LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) UNDER THE BRAZ ...

    May 1, 2009, 00:00

  • PND10 COST-EFFECTIVENESS STUDY IN PATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMERS DISEASE- PROJECTED BENEFITS OF DONEPEZIL IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PIH46 OUTCOMES AND COSTS ASSOCIATED WITH FERTILITY DRUG THERAPY IN AN INSURED POPULATION WITH A STATE FERTILITY MANDATE

    May 1, 2009, 00:00

  • PMC48 'UNNATURAL' HISTORY- MODELING DISEASE PROGRESSION USING OBSERVATIONAL DATA

    May 1, 2009, 00:00

  • PCV55 COST-EFFECTIVENESS OF VALSARTAN IN JAPAN- RESULTS FROM THE JIKEI HEART STUDY

    May 1, 2009, 00:00

  • PDB8 COMPARISON OF DOSING PATTERNS OF DULOXETINE AND PREGABALIN AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN

    May 1, 2009, 00:00

  • PIH23 A SYSTEMATIC REVIEW OF THE COST OF FALLS IN OLDER ADULTS- AN INTERNATIONAL PERSPECTIVE

    May 1, 2009, 00:00

  • PHP92 EVALUATION OF A WIRELESS HANDHELD MEDICATION MANAGEMENT PROGRAM IN THE PREVENTION OF DRUG-DRUG INTERACTIONS

    May 1, 2009, 00:00

  • PIN32 PHARMACOECONOMIC RELEVANCE OF ANTI-RETRO VIRAL THERAPY (ART) IN LOW AND MIDDLE INCOME COUNTRIES

    May 1, 2009, 00:00

  • PCN91 PROVISION OF QUALITY OF LIFE INFORMATION AND PHYSICIAN TRUST AMONG FAMILIES OF CHILDREN WITH LIFE-LIMITED CONDITIONS

    May 1, 2009, 00:00

  • PMC59 PSYCHOMETRIC ASSESSMENT OF AN INSTRUMENT TO MEASURE PATIENT SATISFACTION WITH MEDICATION THERAPY MANAGEMENT SERVICES

    May 1, 2009, 00:00

  • VA2 COST EFFECTIVENESS ANALYSIS OF THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN CANADA

    May 1, 2009, 00:00

  • PND1 PREVALENCE OF INSOMNIA IN EUROPE- A COMPARISON OF FIVE COUNTRIES

    May 1, 2009, 00:00

  • PMH32 ANTIPSYCHOTIC TREATMENT CHOICE AND ASSOCIATED COSTS OF MEDICAL CARE IN PATIENTS WITH SCHIZOPHRENIA

    May 1, 2009, 00:00

  • PIH14 COST-EFFECTIVENESS OF NEONATAL SCREENING FOR CONGENITAL ERRORS OF METABOLISM USING TANDEM MASS SPECTROMETRY

    May 1, 2009, 00:00

  • PCN79 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF NON-HODGKIN LYMPHOMA IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2009, 00:00

  • PCV11 POINT-OF-CARE INR MONITORING DEVICES FOR PATIENTS ON LONG-TERM ORAL ANTICOAGULATION THERAPY

    May 1, 2009, 00:00

  • PCV51 A COST-EFFECTIVENESS ASSESSMENT OF DALTEPARIN AS A PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) IN MEXICAN ADULT PATIENTS AFTER TOTAL HIP REPLACEMENT

    May 1, 2009, 00:00

  • PIH33 LONGITUDINAL VALIDATION OF THE PREMENSTRUAL SYMPTOMS IMPACT SURVEY (PMSIS)

    May 1, 2009, 00:00

  • PMC36 THE POPULATION IMPACT OF CHEMOTHERAPY IN LATE-STAGE PROSTATE CANCER- A SIMULATION STUDY USING TAX327 AND SEER-MEDICARE DATA

    May 1, 2009, 00:00

  • PMH62 PREDICTORS OF OUTPATIENTS VISITS AND EMERGENCY ROOM VISITS IN PATIENTS WITH EARLY PSYCHOTIC ILLNESS

    May 1, 2009, 00:00

  • MS4 SOCIETAL COST OF RHEUMATOID ARTHRITIS (RA) IN THE UNITED STATES- METHODOLOGY FOR INCORPORATING INTANGIBLE COSTS

    May 1, 2009, 00:00

  • PCN52 ECONOMIC EVALUATION OF FULVESTRANT (FASLODEX,) AS AN ADDITIONAL ENDOCRINE STEP IN THE TREATMENT SEQUENCE FOR HORMONE-RECEPTOR POSITIVE ADVANCED AND METASTATIC BREAST CANCER IN ISRAEL

    May 1, 2009, 00:00

  • PHP72 PATIENT PRIVACY AND DATA CONFIDENTIALITY AND THE USE OF SECONDARY DATA

    May 1, 2009, 00:00

  • PDB24 COMPARISON OF GLUCOMETERS USED FOR SELF-MONITORING BLOOD GLUCOSE AMONG DIABETIC PATIENTS- A COST MINIMIZATION APPROACH.

    May 1, 2009, 00:00

  • PCN42 BUDGETARY IMPACT OF METASTATIC RENAL CELL CARCINOMA (MRCC) TREATMENT ON THE COLOMBIAN GENERAL HEALTH SOCIAL SECURITY SYSTEM (SGSSS)

    May 1, 2009, 00:00

  • PHP47 PREDICTING HEALTH SERVICE UTILIZATION WITH THE PCS AND MCS OF THE SF-36

    May 1, 2009, 00:00

  • PCV26 HEALTH CARE UTILIZATION AND RISK OF CARDIOVASCULAR DISEASE ASSOCIATED WITH METABOLIC SYNDROME

    May 1, 2009, 00:00

  • PCASE4 THE EVALUATION PROCESS OF A REGIONAL DRUG AND THERAPEUTIC COMMITTEE IN ITALY- THE EXAMPLE OF NEW INDICATIONS FOR BEVACIZUMAB

    May 1, 2009, 00:00

  • PMS34 AN EXPLORATORY EVALUATION OF THE COST-EFFECTIVENESS OF RITUXIMAB AND ABATACEPT IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO A TUMOUR NECROSIS FACTOR INHIBITOR IN CANADA

    May 1, 2009, 00:00

  • PCN96 ESTIMATING THE TIME OF PRODUCTIVITY LOST OF PATIENTS WITH CANCER AND MUSCULAR-SKELETAL DISEASES IN SLOVAKIA

    May 1, 2009, 00:00

  • PHP77 MEXICAN POSTER PRESENTATIONS AT ISPOR MEETINGS- A QUALITY AND TENDENCY ASSESSMENT 2003-2008

    May 1, 2009, 00:00

  • PMC9 SIGNIFICANCE OF INCORPORATING COMMUNITY-BASED DATA OF A TARGET POPULATION INTO PHARMACOECONOMIC MODELS

    May 1, 2009, 00:00

  • MS1 ASSESSMENT OF PREFERENCE AND SATISFACTION WITH A WEEKLY ORAL TABLET VERSUS A 6-MONTH SUBCUTANEOUS INJECTION FOR THE TREATMENT OF OSTEOPOROSIS

    May 1, 2009, 00:00

  • PSS2 DISTRIBUTION OF PATHOGENS ASSOCIATED WITH ACUTE OTITIS MEDIA- A SYSTEMATIC REVIEW OF THE LITERATURE

    May 1, 2009, 00:00

  • PMH36 COMPARISON OF HOSPITALIZATIONS AND HEALTH CARE COSTS OF ELDERLY MAJOR DEPRESSIVE DISORDER (MDD) PATIENTS TREATED WITH ESCITALOPRAM, GENERIC SSRIS, OR SNRIS

    May 1, 2009, 00:00

  • PSY11 ESTIMATION OF CAUSAL EFFECTS OF PHYSICAL ACTIVITY ON OBESITY BY A RECURSIVE BIVARIATE PROBIT MODEL

    May 1, 2009, 00:00

  • ND2 DIRECT HEALTH CARE AND WORKLOSS BURDEN OF CHEMOTHERAPY-ASSOCIATED PERIPHERAL NEUROPATHY IN BREAST, OVARIAN, HEAD AND NECK, AND NON-SMALL CELL LUNG CANCER

    May 1, 2009, 00:00

  • PUK17 THE FDA DRAFT GUIDANCE ON PATIENT-REPORTED OUTCOMES CAN BE USED TO IMPROVE THE ESTIMATION OF UTILITIES. A CASE STUDY IN CHRONIC KIDNEY DISEASE

    May 1, 2009, 00:00

  • PMH71 OFF-LABEL PRESCRIPTION RATE OF ANTIDEPRESSANTS AMONG OFFICE BASED PHYSICIAN AND HOSPITAL OUTPATIENT PRACTICES DURING 2003-2005

    May 1, 2009, 00:00

  • PCN21 BUDGET IMPACT ANALYSIS OF NON - SMALL CELL LUNG CARCINOMA (NSCLC) TREATMENT WITH ERLOTINIB IN POLISH SETTING

    May 1, 2009, 00:00

  • PND32 PREDICTORS OF PATIENT- AND PHYSICIAN-REPORTED SATISFACTION/ EASE-OF-USE RATINGS WITH RASAGILINE IN PARKINSONS DISEASE

    May 1, 2009, 00:00

  • PHP85 REVIEW OF HTA RECOMMENDATIONS FOR DRUG THERAPIES IN POLAND ISSUED FROM SEPTEMBER 6, 2007 UNTIL OCTOBER 28, 2008 BY THE CONSULTATIVE COUNCIL (APPRAISAL COMMITTEE) OF AHTAPOL IN POLAND

    May 1, 2009, 00:00

  • PHP81 ADDRESSING THE CHALLENGE OF IMPLEMENTING HEALTH TECHNOLOGIES- THE SPANISH EXPERIENCE

    May 1, 2009, 00:00

  • PMS12 FIBROMYALGIA- RUSSIAN RHEUMATOLOGISTS KNOWLEDGE

    May 1, 2009, 00:00

  • PIN23 APPLYING THE EFFICIENCY FRONTIER IN PHARMACEUTICAL POLICY MAKING. A CASE STUDY IN TREATMENT RESISTANT HIV/AIDS PATIENTS IN THE GERMAN SETTING

    May 1, 2009, 00:00

  • PDB7 ADMINISTRATIVE CLAIMS ANALYSIS OF PATIENTS WITH TYPE-2 DIABETES INITIATING SITAGLIPTIN THERAPY

    May 1, 2009, 00:00

  • PMH54 PATIENT-REPORTED HEALTH STATUS IN CHRONIC MEDICAL DISORDER PATIENTS WITH AND WITHOUT DEPRESSION IN THE UNITED STATES, 2004-2005

    May 1, 2009, 00:00

  • VA3 A GLOBAL COST-EFFECTIVENESS EVALUATION OF THE IMPACT OF POTENTIAL INNOVATIONS IN MEASLES VACCINATION

    May 1, 2009, 00:00

  • PHP80 AN EVALUATION OF PHARMACOECONOMICS EDUCATION IN COLLEGES OF PHARMACY OUTSIDE THE UNITED STATES 2007-2008 UPDATE

    May 1, 2009, 00:00

  • PND11 COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMERS DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PGI13 RESPONSIVENESS TO CHANGE AND CLINICALLY RELEVANT IMPROVEMENTS OF THE SF-36 QUESTIONNAIRE IN SWEDISH PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

    May 1, 2009, 00:00

  • PCN35 COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINE IN COLOMBIA IN 2007

    May 1, 2009, 00:00

  • PSS1 META-ANALYSIS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS

    May 1, 2009, 00:00

  • PCN44 PHARMACOECONOMICAL ASPECT OF ONCOLOGICAL THERAPY

    May 1, 2009, 00:00

  • PCV60 ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS- RESULTS FROM THE ENDEAVOR III TRIAL

    May 1, 2009, 00:00

  • PHP45 VARIABILITY OF FEES IN THE FIELD OF PHYSICAL THERAPY IN THE AUSTRIAN CONTRACT PHYSICIANS SECTOR

    May 1, 2009, 00:00

  • PHP36 EFFECT OF THE INTRODUCTION OF VISIT FEE ON THE NUMBER OF VISITS TO GENERAL PRACTITIONERS IN HUNGARY

    May 1, 2009, 00:00

  • PUK8 THE COST-EFFECTIVENESS OF PARICALCITOL VERSUS STANDARD TREATMENT FOR SECONDARY HYPERPARATHYROIDISM - MULTICOUNTRY PERSPECTIVES

    May 1, 2009, 00:00

  • PCV15 EFFECT OF STATIN THERAPY ON RISK OF CORONARY DISEASE IN PRIMARY AND SECONDARY PREVENTION TRIALS- A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2009, 00:00

  • PIH42 WORK DISABILITY AND RETIREMENT IN DUAL-EARNER FAMILIES

    May 1, 2009, 00:00

  • PMH27 INPATIENT COST OF SCHIZOPHRENIA TREATMENT IN TURKEY

    May 1, 2009, 00:00

  • PMC58 TEST-RETEST RELIABILITY OF THE EQ-5D VISUAL ANALOG SCALE ACROSS POPULATIONS AND CONDITIONS

    May 1, 2009, 00:00

  • PCV48 USING EXPERT ELICITATION TO INFORM ADOPTION AND RESEARCH DECISIONS FOR ENHANCED EXTERNAL COUNTERPULSATION IN ANGINA

    May 1, 2009, 00:00

  • PMS2 GOUT AND THE RISK OF ACUTE MYOCARDIAL INFARCTION AMONG ELDERLY WOMEN

    May 1, 2009, 00:00

  • PCN75 THE IMPACT OF NEUTROPENIC COMPLICATIONS ON SHORT-TERM DISABILITY IN PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY

    May 1, 2009, 00:00

  • PCV90 PHARMACEUTICAL SPENDING ON CHRONIC DISEASES IN CONSUMER DIRECTED HEALTH PLANS

    May 1, 2009, 00:00

  • PHP30 A SYSTEMATIC LITERATURE REVIEW OF ELECTRONIC MONITORING DEVICES FOR MEASURING MEDICATION ADHERENCE

    May 1, 2009, 00:00

  • PMC38 VALIDATION OF THE IHE/JJ ECONOMIC SIMULATION MODEL OF TYPE-2 DIABETES MELLITUS (T2DM)

    May 1, 2009, 00:00

  • PRS34 EQ-5D BASED QOL ASSESSMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) IN JAPAN

    May 1, 2009, 00:00

  • PDB38 THE EFFECT OF WEIGHT CHANGES ON HEALTH-RELATED QUALITY OF LIFE AND WORK IMPAIRMENT IN PATIENTS WITH TYPE 2 DIABETES

    May 1, 2009, 00:00

  • CASE3 HEALTH SERVICES PHARMACEUTICAL COVERAGE FOR COMMON DISEASES MAY BE CHALLENGED BY SIGNIFICANT RISE IN ONCOLOGY DRUG EXPENDITURE

    May 1, 2009, 00:00

  • PDB36 IMPACT OF TREATMENT COMPLEXITY ON ADHERENCE AND GLYCEMIC CONTROL- AN ANALYSIS OF ORAL ANTI-DIABETIC AGENTS

    May 1, 2009, 00:00

  • PCN33 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB ASSOCIATED TO BEST SUPPORTIVE CARE (BSC) VERSUS BEST SUPPORTIVE CARE ALONE IN THE SECOND LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIV ...

    May 1, 2009, 00:00

  • PSY47 CROHNS DISEASE TREATMENT PARADIGM

    May 1, 2009, 00:00

  • PHP58 FACTORS ASSOCIATED WITH REPEAT ATTENDANCE AT EMERGENCY DEPARTMENT (ED) OF A SECONDARY CARE HOSPITAL IN SINGAPORE

    May 1, 2009, 00:00

  • PCV58 TRIAL-BASED ECONOMIC EVALUATION ALONGSIDE THE TCYB (TAKE CONTROL OF YOUR BLOOD PRESSURE) TRIAL

    May 1, 2009, 00:00

  • PSS5 A COST COMPARISON OF ADALIMUMAB AND ETANERCEPT FOR THE TREATMENT OF CHRONIC PLAQUE PSORIASIS IN THE UNITED KINGDOM

    May 1, 2009, 00:00

  • PUK10 LONG-TERM COST EFFECTIVENESS OF SIROLIMUS REGIMEN COMPARED WITH CALCINEURIN INHIBITOR REGIMENS FOR IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION IN KOREA

    May 1, 2009, 00:00

  • PIH26 THE ECONOMIC IMPACT OF SINGLETON, TWIN AND MULTIPLE GESTATION PREGNANCIES IN ALBERTA

    May 1, 2009, 00:00

  • HM2 USING DECISION MODELING TO MAP PHARMACISTS INTERVENTIONS TO OUTCOMES FOR PATIENTS WITH DIABETES

    May 1, 2009, 00:00

  • PGI7 COST-EFFECTIVENESS ANALYSIS OF ADALIMUMAB VS. CERTOLIZUMAB MAINTENANCE THERAPIES FOR MODERATE TO SEVERE CROHNS DISEASE

    May 1, 2009, 00:00

  • PHP21 USING EXPLICIT CRITERIA TO EVALUATE INAPPROPRIATE PRESCRIBING IN ELDERLY OUTPATIENTS- A COHORT STUDY

    May 1, 2009, 00:00

  • PMC10 COMPARISON BETWEEN PROPENSITY SCORE AND TRADITIONAL COVARIATE ADJUSTMENT WITH LOGISTIC REGRESSION MODELS IN ESTIMATING THE AVERAGE TREATMENT EFFECTS (ATES)- RESULTS FROM MONTE CARLO SIMULATIONS

    May 1, 2009, 00:00
  • «
  • 151
  • 152 (current)
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »